Rivercell raises $25M seed to build an AI world model of the cell

Paris-based Rivercell has secured significant seed funding to develop an AI "world model" of the cell. This simulation aims to predict cellular responses to drugs and genetic changes, addressing a critical gap in medical research where no large-scale public dataset currently exists for dynamic cell behavior over time. By creating its own data, the company seeks to transform how biology is understood and engineered. The venture addresses limitations in existing biological data, which often lacks intervention testing and temporal depth. Rivercell plans to generate comprehensive datasets by filming living cells and measuring gene activity, using AI to autonomously select and execute subsequent experiments. This approach, supported by specialized instrumentation, is designed to drastically reduce the number of physical lab experiments required, accelerating the discovery process through iterative, data-driven cycles. This initiative is highly relevant to open_data as it highlights the urgent need for high-quality, standardized biological datasets to train effective AI models. Unlike AlphaFold, which leveraged public structural data, Rivercell acknowledges that such open resources are missing for cellular dynamics. Its success depends on generating rich, accessible data, potentially setting a new standard for how biological insights are collected and shared within the scientific community.

Source: thenextweb.com
Published on 2026-10-08

Rivercell raises $25M seed to build an AI world model of the cell

Related news